Repligen Aktie
					
						
							123,45
						
						EUR
					
					
						
							+8,75
						
						EUR
					
					
						
							+7,63
						
						%
					
				
				
				
					
						
							149,34
						
						USD
					
					
						
							+4,81
						
						USD
					
					
						
							+3,33
						
						%
					
				
				
		
		
		
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                Repligen Aktie Analyse
| 28.08.19 | Repligen Outperform | First Analysis Securities | |
| 22.07.19 | Repligen Buy | H.C. Wainwright & Co. | |
| 26.09.18 | Repligen Neutral | H.C. Wainwright & Co. | |
| 02.10.17 | Repligen Overweight | First Analysis Securities | |
| 29.10.09 | Repligen buy | Merriman Curhan Ford & Co | |
| 30.06.09 | Repligen buy | Merriman Curhan Ford & Co | |
| 13.06.08 | Repligen market outperform | Rodman & Renshaw, LLC | |
| 20.05.08 | Repligen | Global Biotech Investing | |
| 
                            
        Werbung
    
                         | |||
| 11.09.07 | Repligen market outperform | Rodman & Renshaw | |
| 12.04.07 | Repligen market outperform | Rodman & Renshaw | |
| 29.12.05 | Repligen overweight | Lehman Brothers | |
| 27.05.05 | Repligen market outperform | Rodman & Renshaw | |
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                 
                                